July 2, 2012–FDA Approves Cornerstone Therapeutics’ ANDA for Generic Tussionex® Pennkinetic® Product. Coating Place Inc. (CPI) developed the active drug substances, Hydrocodone Polistirex and Chlorpheniramine Polistirex, using our Patented DRC Technology. These active drug substances will be manufactured at commercial scale in the CPI facilities.

View Press Release Here

 

THE WURSTER PROCESS

THE WURSTER PROCESS

Find Out More

DID YOU KNOW?

  • Coating Place has over 30 years of experience developing ion-exchange products. 

More

Coating Place, Inc. 200 Paoli Street | PO Box 930310 | Verona, WI 53593.   Phone: (608) 845-9521   Fax: (608) 845-9526
footer-rgt